174 related articles for article (PubMed ID: 35895180)
1. Endoscopic surveillance alone is feasible and safe in type I gastric neuroendocrine neoplasms less than 10 mm in diameter.
Exarchou K; Hu H; Stephens NA; Moore AR; Kelly M; Lamarca A; Mansoor W; Hubner R; McNamara MG; Smart H; Howes NR; Valle JW; Pritchard DM
Endocrine; 2022 Oct; 78(1):186-196. PubMed ID: 35895180
[TBL] [Abstract][Full Text] [Related]
2. Is local excision sufficient in selected grade 1 or 2 type III gastric neuroendocrine neoplasms?
Exarchou K; Kamieniarz L; Tsoli M; Victor A; Oleinikov K; Khan MS; Srirajaskanthan R; Mandair D; Grozinsky-Glasberg S; Kaltsas G; Howes N; Pritchard DM; Toumpanakis C
Endocrine; 2021 Nov; 74(2):421-429. PubMed ID: 34120313
[TBL] [Abstract][Full Text] [Related]
3. [Consensus and controversy on subtype classification of gastric neuroendocrine neoplasms].
Tan H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):977-981. PubMed ID: 28900986
[TBL] [Abstract][Full Text] [Related]
4. Selective Resection of Type 1 Gastric Neuroendocrine Neoplasms and the Risk of Progression in an Endoscopic Surveillance Programme.
Chin JL; O'Connell J; Muldoon C; Swan N; Reynolds JV; Ravi N; Geoghegan J; Conlon KC; O'Shea D; O'Toole D
Dig Surg; 2021; 38(1):38-45. PubMed ID: 33260173
[TBL] [Abstract][Full Text] [Related]
5. Patterns of Lymph Node Metastasis in Patients With T1/T2 Gastroduodenal Neuroendocrine Neoplasms: Implications for Endoscopic Treatment.
Zhou YJ; Wang QW; Zhang QW; Chen JN; Wang XY; Gao YJ; Li XB
Front Endocrinol (Lausanne); 2021; 12():658392. PubMed ID: 34122337
[TBL] [Abstract][Full Text] [Related]
6. Advances in Endoscopic Diagnosis and Treatment of Gastric Neuroendocrine Neoplasms.
Guo X; Zhao X; Huang G; Yu Y
Dig Dis Sci; 2024 Jan; 69(1):27-35. PubMed ID: 37971578
[TBL] [Abstract][Full Text] [Related]
7. [Clinical features and prognostic factors of primary gastric neuroendocrine neoplasms].
Xiong YJ; Liu XY; Cheng CE; Chen C; Sun YB; Tan CH; Liu YT; Feng J; Ma YF; Shi DT; Li R; Tang QY
Zhonghua Nei Ke Za Zhi; 2020 Apr; 59(4):297-302. PubMed ID: 32209196
[No Abstract] [Full Text] [Related]
8. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
[TBL] [Abstract][Full Text] [Related]
9. Management and disease outcome of type I gastric neuroendocrine tumors: the Mount Sinai experience.
Chen WC; Warner RR; Ward SC; Harpaz N; Divino CM; Itzkowitz SH; Kim MK
Dig Dis Sci; 2015 Apr; 60(4):996-1003. PubMed ID: 25399327
[TBL] [Abstract][Full Text] [Related]
10. [Subtype classification and clinicopathological characteristics of gastric neuroendocrine neoplasms: an analysis of 241 cases].
Zhang P; Zhang Y; Zhang C; Shi Y; Liu J; Liu Q; Yu L; Wang M; Zou G; Lou J; Chen J; Tan H
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1241-1246. PubMed ID: 27928793
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China.
Fang C; Wang W; Zhang Y; Feng X; Sun J; Zeng Y; Chen Y; Li Y; Chen M; Zhou Z; Chen J
Chin J Cancer; 2017 Jun; 36(1):51. PubMed ID: 28637502
[TBL] [Abstract][Full Text] [Related]
12. Surgical treatment and prognosis of gastric neuroendocrine neoplasms: a single-center experience.
Shen C; Chen H; Chen H; Yin Y; Han L; Chen J; Tang S; Yin X; Zhou Z; Zhang B; Chen Z
BMC Gastroenterol; 2016 Sep; 16(1):111. PubMed ID: 27613657
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic techniques for diagnosis and treatment of gastro-entero-pancreatic neuroendocrine neoplasms: Where we are.
Rossi RE; Elvevi A; Gallo C; Palermo A; Invernizzi P; Massironi S
World J Gastroenterol; 2022 Jul; 28(26):3258-3273. PubMed ID: 36051341
[TBL] [Abstract][Full Text] [Related]
14. New Developments in Gastric Neuroendocrine Neoplasms.
Exarchou K; Stephens NA; Moore AR; Howes NR; Pritchard DM
Curr Oncol Rep; 2022 Jan; 24(1):77-88. PubMed ID: 35059996
[TBL] [Abstract][Full Text] [Related]
15. Limited role of carbidopa-assisted
Imperiale A; Averous G; Helali M; Taieb D; Pessaux P; Goichot B; Addeo P; Bachellier P
Ann Nucl Med; 2019 Sep; 33(9):697-707. PubMed ID: 31214959
[TBL] [Abstract][Full Text] [Related]
16. [Pathological characteristics and survival analysis of 355 patients with gastroenteropancreatic neuroendocrine neoplasms].
Li Y; Wang YF; Tan BB; Er LM; Zhao Q; Fan LQ; Zhang ZD; Liu Y
Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):426-431. PubMed ID: 32482035
[No Abstract] [Full Text] [Related]
17. Gastric neuroendocrine neoplasms: A review.
Köseoğlu H; Duzenli T; Sezikli M
World J Clin Cases; 2021 Sep; 9(27):7973-7985. PubMed ID: 34621854
[TBL] [Abstract][Full Text] [Related]
18. [Endoscopic therapy for gastroduodenal neuroendocrine neoplasms].
Maasberg S; Jürgensen C; Scheerer F; Pschowski R; Felder S; Begum N; Wiedenmann B; Pascher A; Pape UF
Chirurg; 2016 Apr; 87(4):271-9. PubMed ID: 26960437
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of endoscopic resection for type I gastric neuroendocrine tumors.
Uygun A; Kadayifci A; Polat Z; Yilmaz K; Gunal A; Demir H; Bagci S
J Surg Oncol; 2014 Feb; 109(2):71-4. PubMed ID: 24165913
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathologic characteristics and prognosis of rectal neuroendocrine neoplasms].
Liu T; Liu P; Wu T; Pan Y; Chen G; Wang P; Jiang Y; Wu Y; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1015-1019. PubMed ID: 28900992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]